9.1 Wound Healing, Surgical Site Infections & Gas Gangrene

9.1 Wound Healing, Surgical Site Infections & Gas Gangrene

UPSC CMS High-Yield Core Focus: Mastery of wound healing phases, cell types involved, collagen subtype transitions, local and systemic factors impairing healing, CDC classification of surgical site infections (SSIs), antibiotic prophylaxis timing, and the emergency surgical management of clostridial myonecrosis (gas gangrene).

---

1. Phases of Normal Wound Healing

Wound healing is a complex, dynamic physiological cascade organized into three overlapping phases: Hemostasis & Inflammation, Proliferation, and Remodeling & Maturation.

Phase 1: Hemostasis and Inflammation (Days 0 – 4)

• Immediate Hemostasis: Injury disrupts blood vessels, exposing subendothelial collagen. Platelets aggregate, activating the intrinsic and extrinsic coagulation cascades to form a fibrin-fibronectin clot. Platelets release key alpha-granule growth factors: Platelet-Derived Growth Factor (PDGF) and Transforming Growth Factor-beta (TGF-β).
• Neutrophil Infiltration (24 – 48 hours): Vasodilation and increased capillary permeability (mediated by histamine, serotonin, and prostaglandins) allow polymorphonuclear neutrophils (PMNs) to marginate and migrate into the wound matrix. Neutrophils phagocytose bacteria and debris via reactive oxygen species and lysosomal enzymes.
• Macrophage Arrival (48 – 72 hours): Monocytes differentiate into macrophages upon entering the wound. Macrophages are the indispensable orchestrators of wound healing. They clear remaining debris and secrete essential cytokines: PDGF, TGF-β, Fibroblast Growth Factor (FGF), and Vascular Endothelial Growth Factor (VEGF), which recruit fibroblasts and stimulate endothelial cell proliferation.

Phase 2: Proliferation and Granulation (Days 4 – 21)

• Fibroplasia & Matrix Synthesis: Fibroblasts migrate into the wound along the fibronectin scaffold under the influence of PDGF and TGF-β. Fibroblasts synthesize extracellular matrix components, predominantly Type III collagen (immature, thin, non-cross-linked collagen).
• Neovascularization (Angiogenesis): Endothelial cells proliferate in response to VEGF and basic FGF, forming delicate new capillary loops that impart a granular, red appearance (granulation tissue).
• Epithelialization: Basal keratinocytes from wound margins and epidermal appendages (hair follicles, sweat glands) migrate across the granulation tissue to restore epidermal integrity.
• Wound Contraction: Differentiated myofibroblasts (containing alpha-smooth muscle actin) exert mechanical traction, pulling wound edges inward to decrease overall surface area.

Phase 3: Remodeling and Maturation (Day 21 – 1 Year)

• Collagen Subtype Transition: Matrix Metalloproteinases (MMPs) secreted by fibroblasts degrade weak Type III collagen, which is systematically replaced by dense, organized Type I collagen oriented along lines of mechanical stress (Langer's lines).
• Tensile Strength Accumulation: At 3 weeks, wound tensile strength is only ~20% of normal skin. Remodeling increases strength over 6 to 12 months, reaching a maximum plateau of 70–80% of original, uninjured skin strength. Scar tissue never achieves 100% of original tensile strength.

---

2. Modes of Wound Closure (Intention)

---

3. Factors Impairing Wound Healing

Systemic Factors

• Malnutrition & Hypoproteinemia: Protein deficiency impairs fibroblast proliferation and collagen synthesis. Serum albumin <3.0 g/dL significantly increases wound dehiscence risk.
• Vitamin Deficiencies:
  • Vitamin C (Ascorbic Acid): Essential cofactor for prolyl and lysyl hydroxylase. Deficiency (scurvy) prevents triple-helix collagen stabilization, leading to unformed collagen and wound breakdown.
  • Vitamin A: Promotes epithelialization and fibronectin synthesis. Reverses the inhibitory effects of systemic corticosteroids on wound healing.
  • Zinc Deficiency: Impairs DNA synthesis, cell division, and MMP activity.
• Diabetes Mellitus: Microvascular disease causes tissue hypoxia; hyperglycemia impairs neutrophil chemotaxis, phagocytosis, and collagen cross-linking.
• Systemic Corticosteroids: Inhibit macrophage activation, TGF-β release, collagen synthesis, and wound contraction.
• Jaundice & Uremia: High bilirubin levels and nitrogenous wastes blunt cellular immune response and collagen deposition.

Local Factors

• Tissue Ischemia & Hypoxia: Inadequate blood supply (arterial disease, excessive suture tension, localized edema).
• Infection: Bacterial load >$10^5$ organisms per gram of tissue disrupts healing by prolonging inflammation and destroying extracellular matrix via bacterial proteases.
• Foreign Material & Necrotic Tissue: Serves as a nidus for infection and physical barrier to healing.
• Ionizing Radiation: Induces endarteritis obliterans, causing permanent tissue ischemia and fibrosis.

---

4. Pathological Scarring: Hypertrophic Scars vs. Keloids

---

5. Surgical Site Infections (SSIs)

According to the Centers for Disease Control and Prevention (CDC), SSIs are categorized by anatomical depth and must occur within 30 days of surgery (or within 90 days if a permanent surgical implant is placed).

CDC Classification of SSIs

1. Superficial Incisional SSI: Involves only skin and subcutaneous tissue. Symptoms: Purulent drainage, localized pain, warmth, erythema, or positive culture.
2. Deep Incisional SSI: Involves deep soft tissues (fascia and muscle layers). Symptoms: Deep purulent drainage, spontaneous dehiscence, or deep abscess on clinical/radiological exam.
3. Organ/Space SSI: Involves any anatomical space opened or manipulated during the operation (e.g., intra-abdominal abscess, subphrenic collection, empyema).

Surgical Wound Classification & Infection Risk

• Clean Wounds (1–2% SSI Risk): Uninfected operative wound; no inflammation encountered; respiratory, GI, and GU tracts NOT entered. Examples: Elective thyroidectomy, inguinal hernia repair, mastectomy.
• Clean-Contaminated Wounds (2–10% SSI Risk): Operative wound in which respiratory, GI, or GU tracts are entered under controlled conditions without unusual contamination. Examples: Elective cholecystectomy, elective gastrectomy, appendectomy without perforation.
• Contaminated Wounds (10–20% SSI Risk): Open, fresh traumatic wounds; operations with major breaks in sterile technique or gross spillage from GI tract. Examples: Acute non-perforated appendicitis, open fracture within 4 hours.
• Dirty / Infected Wounds (>20% SSI Risk): Old traumatic wounds with retained devitalized tissue; existing clinical infection or perforated viscus. Examples: Perforated appendicitis with fecal peritonitis, diverticular abscess.

Antibiotic Prophylaxis Guidelines

• Timing: Single IV dose administered within 60 minutes prior to skin incision (within 120 minutes for vancomycin or fluoroquinolones) to ensure peak tissue drug concentration during incision.
• Agent Selection: First- or second-generation cephalosporin (e.g., Cefazolin IV) for clean/clean-contaminated procedures; add Metronidazole for colorectal surgery.
• Redosing: Re-dose intraoperatively if procedure duration exceeds 2 half-lives of the antibiotic (e.g., >3–4 hours for Cefazolin) or if blood loss exceeds 1,500 mL.

---

6. Gas Gangrene (Clostridial Myonecrosis)

Etiology & Pathophysiology

• Causative Organism: Clostridium perfringens (Type A), an obligate anaerobic, spore-forming Gram-positive bacillus, accounts for 80–90% of cases. Other species include C. septicum and C. novyi.
• Predisposing Factors: Deep crush injuries, high-velocity gunshot wounds, soil-contaminated compound fractures, or ischemic surgical stumps.
• Toxin Mechanism: C. perfringens produces Alpha-toxin (a lecithinase / phospholipase C) that cleaves cell membrane phospholipids, causing widespread necrosis of muscle cells, red blood cell lysis (intravascular hemolysis), and microvascular thrombosis leading to extensive tissue ischemia.

Clinical Presentation

• Rapid Onset: Symptoms develop rapidly, typically within 12 to 48 hours post-injury.
• Symptoms & Signs:
  • Sudden, severe, excruciating wound pain out of proportion to physical appearance.
  • Pale, tense, edematous skin that rapidly transitions to a dark reddish-purple or bronze discoloration with dirty bullae.
  • Profuse, thin, brownish, foul-smelling discharge described as "dishwater fluid".
  • Soft tissue crepitus (palpable gas pockets in muscle planes and subcutis).
  • Systemic Toxicity: Marked tachycardia, high fever, jaundice (secondary to intravascular hemolysis), profound hypotension, and rapid progression to septic shock and multi-organ failure.

Diagnosis & Emergency Surgical Protocol

• Microbiology: Gram stain of discharge reveals large, Gram-positive, boxcar-shaped bacilli with a conspicuous absence of polymorphonuclear leukocytes (destroyed by clostridial toxins).
• Radiology: Soft tissue plain radiograph or CT demonstrates extensive gas feathery dissecting along fascial and muscle planes.
• Emergency Surgical Management:
  1. Immediate Radical Surgical Debridement: Emergency longitudinal fasciotomies and excision of all necrotic, non-viable muscle tissue until healthy, contractile, bleeding muscle is reached. Amputation may be life-saving for gangrenous limbs.
  2. High-Dose Antimicrobial Therapy: Intravenous Benzylpenicillin (3–4 million units IV every 4 hours) combined with Clindamycin (600–900 mg IV every 8 hours; clindamycin suppresses bacterial toxin synthesis).
  3. Adjuvant Hyperbaric Oxygen Therapy (HBO): High arterial oxygen tension inhibits anaerobic clostridial growth and inactivates alpha-toxin production.
  4. Aggressive Resuscitation: ICU admission for fluid resuscitation, blood transfusion for hemolysis, and hemodynamic vasopressor support.